HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients.

AuthorsF Kanefendt, A Lindauer, M Kinzig, D Strumberg, M E Scheulen, K Mross, R Fischer, B Moritz, F Sörgel, U Jaehde
JournalInternational journal of clinical pharmacology and therapeutics (Int J Clin Pharmacol Ther) Vol. 49 Issue 1 Pg. 88-90 (Jan 2011) ISSN: 0946-1965 [Print] Germany
PMID21176741 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Indoles
  • Pyrroles
  • SU 12662
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-2
  • Vascular Endothelial Growth Factor Receptor-3
  • Sunitinib
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor (blood)
  • Colorectal Neoplasms (drug therapy, pathology)
  • Female
  • Humans
  • Indoles (therapeutic use)
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Pyrroles (therapeutic use)
  • Sunitinib
  • Vascular Endothelial Growth Factor A (blood)
  • Vascular Endothelial Growth Factor Receptor-2 (analysis)
  • Vascular Endothelial Growth Factor Receptor-3 (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: